Clearpoint Liabilities And Stockholders Equity from 2010 to 2024
| CLPT Stock | USD 5.87 0.35 6.34% |
Liabilities And Stockholders Equity | First Reported 2011-12-31 | Previous Quarter 43.8 M | Current Value 42.7 M | Quarterly Volatility 21.8 M |
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 366.7 K or Selling General Administrative of 7.5 M, as well as many exotic indicators such as Price To Sales Ratio of 7.13, Dividend Yield of 0.0 or PTB Ratio of 8.29. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
Clearpoint | Liabilities And Stockholders Equity |
Latest Clearpoint Neuro's Liabilities And Stockholders Equity Growth Pattern
Below is the plot of the Liabilities And Stockholders Equity of Clearpoint Neuro over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Clearpoint Neuro's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
| Liabilities And Stockholders Equity | 10 Years Trend |
|
Liabilities And Stockholders Equity |
| Timeline |
Clearpoint Liabilities And Stockholders Equity Regression Statistics
| Arithmetic Mean | 20,043,060 | |
| Geometric Mean | 13,076,494 | |
| Coefficient Of Variation | 98.31 | |
| Mean Deviation | 15,516,657 | |
| Median | 11,926,437 | |
| Standard Deviation | 19,704,998 | |
| Sample Variance | 388.3T | |
| Range | 62.6M | |
| R-Value | 0.74 | |
| Mean Square Error | 189.4T | |
| R-Squared | 0.55 | |
| Significance | 0 | |
| Slope | 3,258,883 | |
| Total Sum of Squares | 5436T |
Clearpoint Liabilities And Stockholders Equity History
About Clearpoint Neuro Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Clearpoint Neuro income statement, its balance sheet, and the statement of cash flows. Clearpoint Neuro investors use historical funamental indicators, such as Clearpoint Neuro's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may use each financial statement separately, they are all related. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearpoint Neuro's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Clearpoint Neuro Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Clearpoint Neuro. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Liabilities And Stockholders Equity | 42.7 M | 23.2 M |
Pair Trading with Clearpoint Neuro
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clearpoint Neuro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will appreciate offsetting losses from the drop in the long position's value.Moving against Clearpoint Stock
| 0.74 | EHC | Encompass Health Corp | PairCorr |
| 0.73 | BSX | Boston Scientific Corp | PairCorr |
| 0.72 | INSP | Inspire Medical Systems Earnings Call This Week | PairCorr |
| 0.51 | DXCM | DexCom Inc | PairCorr |
| 0.5 | VTAK | Catheter Precision Symbol Change | PairCorr |
The ability to find closely correlated positions to Clearpoint Neuro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clearpoint Neuro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clearpoint Neuro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clearpoint Neuro to buy it.
The correlation of Clearpoint Neuro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clearpoint Neuro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clearpoint Neuro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clearpoint Neuro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Clearpoint Neuro Correlation against competitors. For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Clearpoint Stock analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Clearpoint Neuro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearpoint Neuro. If investors know Clearpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 0.974 | Quarterly Revenue Growth 0.316 | Return On Assets (0.29) | Return On Equity (0.76) |
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearpoint Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearpoint Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearpoint Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.